Telma-MCT 25/6.25 Tablet ER
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Chlorthalidone (6.25mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg)
Overview Telma-MCT 25/6.25 Tablet ER
Telma-MCT 25/6.25 ER tablets combine medications to manage hypertension (high blood pressure). This treatment lowers blood pressure by promoting blood vessel dilation and enhancing cardiac output. Fluid and electrolyte excretion are also facilitated. This extended-release formulation may be consumed with or without food, but consistent timing maximizes efficacy. Increased urination is a common effect; daytime administration, or at least four hours before sleep, minimizes nighttime bathroom trips. Dosage and frequency are determined by your physician based on individual needs and should adhere to their prescribed regimen. Treatment should continue as directed. Common side effects include nausea, diarrhea, indigestion, headache, and lightheadedness. Regular kidney function and electrolyte level monitoring are crucial. Optimal outcomes require lifestyle modifications including balanced nutrition, regular physical activity, and smoking cessation. Ample fluid intake helps counteract potential dry mouth or thirst. Prior to commencing treatment, inform your physician of any pregnancy, circulatory disorders, liver or kidney ailments, or other medications you are using, as interactions can affect treatment efficacy.
Uses of Telma-MCT 25/6.25 Tablet ER
Elevated blood pressure
Major Benefits of Telma-MCT 25/6.25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telma-MCT 25/6.25 Tablet ER whole; avoid chewing, crushing, or breaking it. This extended-release tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Telma-MCT 25/6.25 Tablet ER:
- Nausea
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Cold extremities
- Numbness of extremity
- Increased blood lipid level
- Slow heart rate
- Decreased blood pressure
How to use Telma-MCT 25/6.25 Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telma-MCT 25/6.25 Extended-Release Tablets may be consumed with or without food, although consistent daily timing is recommended.
How Telma-MCT 25/6.25 Tablet ER works:
Chlorthalidone, a diuretic, facilitates the excretion of excess fluid and electrolytes via urine, concurrently promoting vasodilation and improved circulation with prolonged use. Metoprolol succinate, a beta-adrenergic blocking agent, reduces cardiac rate by targeting the heart. Meanwhile, telmisartan, an angiotensin receptor blocker, lowers blood pressure through the inhibition of angiotensin II, resulting in further vascular relaxation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telma-MCT 25/6.25 ER tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telma-MCT 25/6.25mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Telma-MCT 25/6.25 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Telma-MCT 25/6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, the extended-release Telma-MCT 25/6.25 tablet requires careful administration. Dosage modification may be necessary; physician consultation is advised. This medication is generally unsuitable for such patients.
LiverCAUTION
Patients with hepatic impairment should use Telma-MCT 25/6.25 mg extended-release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The medication is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Telma-MCT 25/6.25 Tablet ER :
Should you forget to take your Telma-MCT 25/6.25 Tablet ER, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid doubling the prescribed dosage.
Facts to Know About Telma-MCT 25/6.25 Tablet ER
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Heart |